利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.038 秒)

    P2Y6 receptor agonists for treating lung diseases
    3.
    发明申请
    P2Y6 receptor agonists for treating lung diseases 有权
    用于治疗肺部疾病的P2Y6受体激动剂

    公开(公告)号：US20070015726A1

    公开(公告)日：2007-01-18

    申请号：US11478338

    申请日：2006-06-28

    申请人： Jose Boyer ,  Sammy Shaver ,  James Douglass ,  Catherine Redick

    发明人： Jose Boyer ,  Sammy Shaver ,  James Douglass ,  Catherine Redick

    IPC分类号： A61K31/7072 ,  A61K31/7076

    CPC分类号： A61K31/7072 ,  A61K31/708 ,  A61K31/7084

    摘要： This invention is directed to a method of enhancing or facilitating the clearance of the lung mucus secretions in a subject. This invention is also directed to a method of facilitating the hydration of the lung mucus secretions in a subject. This invention is further directed to a method of preventing or treating diseases or conditions associated with impaired lung or airway function in a human or other mammal. The method comprises administering to a subject a pharmaceutical composition comprising a therapeutic effective amount of P2Y6 receptor agonist compound, wherein said amount is effective to activate the P2Y6 receptors on the luminal surface of lung epithelia. The P2Y6 receptor agonist compounds useful for this invention include mononucleoside 5′-diphosphates, dinucleoside monophosphate, dinucleoside diphosphates, or dinucleoside triphosphates of general Formula I, or salts, solvates, hydrates thereof.

    摘要翻译： 本发明涉及增强或促进受试者中肺粘液分泌物清除的方法。 本发明还涉及促进受试者中肺粘液分泌物水合的方法。 本发明进一步涉及预防或治疗与人或其他哺乳动物的肺或气道功能受损有关的疾病或病症的方法。 该方法包括向受试者施用包含治疗有效量的P2Y 6受体激动剂化合物的药物组合物，其中所述量有效激活管腔上的P2Y 6受体 肺上皮表面。 可用于本发明的P2Y 6受体激动剂化合物包括单核苷5'-二磷酸酯，二核苷单磷酸酯，二核苷二磷酸酯或通式I的二核苷三磷酸盐，或其盐，溶剂合物，水合物。

    Drug-eluting stents coated with P2Y12 receptor antagonist compound
    4.
    发明申请
    Drug-eluting stents coated with P2Y12 receptor antagonist compound 失效
    药物洗脱支架涂有P2Y12受体拮抗剂化合物

    公开(公告)号：US20060122143A1

    公开(公告)日：2006-06-08

    申请号：US11267834

    申请日：2005-11-04

    申请人： Jose Boyer ,  James Douglass ,  Sammy Shaver

    发明人： Jose Boyer ,  James Douglass ,  Sammy Shaver

    IPC分类号： A61K31/7076 ,  A61K31/7072 ,  C07H19/04 ,  A61K31/675

    CPC分类号： C07H19/04 ,  A61K31/675 ,  A61K31/7072 ,  A61K31/7076 ,  A61K31/7084 ,  C07H19/10 ,  C07H19/20 ,  C07H19/207 ,  C07H21/00

    摘要： The present invention provides a P2Y12 receptor antagonist compound-eluting stent, wherein the stent is coated with one or more P2Y12 receptor antagonist compounds or a pharmaceutically acceptable salt, solvate, or hydrate thereof. When the stent is placed in a narrowed or damaged arterial vessel, a therapeutically effective amount of the P2Y12 receptor antagonist compound is eluted continuously from the stent to the local environment of the stent. The P2Y12 receptor antagonist compound-eluting stents are useful in preventing thrombosis and restenosis, and are effective in inhibiting the contraction of vascular smooth muscle cells, inhibiting cell proliferation, and reducing inflammation.

    摘要翻译： 本发明提供P2Y 12受体拮抗剂化合物洗脱支架，其中支架涂覆有一种或多种P2Y 12受体拮抗剂化合物或其药学上可接受的盐，溶剂化物， 或其水合物。 当支架置于狭窄或损伤的动脉血管中时，治疗有效量的P2Y 12受体拮抗剂化合物从支架连续洗脱至支架的局部环境。 P2Y 12受体拮抗剂化合物洗脱支架可用于预防血栓形成和再狭窄，并且有效抑制血管平滑肌细胞的收缩，抑制细胞增殖和减少炎症。

    Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
    5.
    发明申请
    Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound 失效
    涂有非核苷酸P2Y12受体拮抗剂化合物的药物洗脱支架

    公开(公告)号：US20060121086A1

    公开(公告)日：2006-06-08

    申请号：US11267941

    申请日：2005-11-04

    申请人： Jose Boyer ,  James Douglass ,  Sammy Shaver

    发明人： Jose Boyer ,  James Douglass ,  Sammy Shaver

    IPC分类号： A61K31/519 ,  A61K31/52 ,  A61F2/00

    CPC分类号： A61K31/519 ,  A61F2/82 ,  A61F2250/0067 ,  A61K31/52 ,  A61K31/522 ,  A61K31/7076 ,  A61K31/727 ,  A61K45/06 ,  A61K2300/00

    摘要： The present invention provides a drug-eluting stent, wherein the stent is coated with one or more non-mucleotide P2Y12 receptor antagonist compounds or a pharmaceutically acceptable salt, solvate, or hydrate thereof. When the stent is placed in a narrowed or damaged arterial vessel, a therapeutically effective amount of the P2Y12 receptor antagonist compound is eluted continuously from the stent to the local environment of the stent. The P2Y12 receptor antagonist compound-eluting stents are useful in preventing thrombosis and restenosis, and are effective in inhibiting the contraction of vascular smooth muscle cells, inhibiting cell proliferation, and reducing inflammation.

    摘要翻译： 本发明提供药物洗脱支架，其中支架涂覆有一种或多种非核苷酸P2Y 12受体拮抗剂化合物或其药学上可接受的盐，溶剂合物或水合物。 当支架置于狭窄或损伤的动脉血管中时，治疗有效量的P2Y 12受体拮抗剂化合物从支架连续洗脱至支架的局部环境。 P2Y 12受体拮抗剂化合物洗脱支架可用于预防血栓形成和再狭窄，并且有效抑制血管平滑肌细胞的收缩，抑制细胞增殖和减少炎症。

    Compositions for the treatment of glaucoma or ocular hypertension
    7.
    发明申请
    Compositions for the treatment of glaucoma or ocular hypertension 审中-公开
    用于治疗青光眼或高眼压症的组合物

    公开(公告)号：US20050130931A1

    公开(公告)日：2005-06-16

    申请号：US11049201

    申请日：2005-02-01

    申请人： Jose Boyer ,  Benjamin Yerxa ,  Robert Plourde ,  Edward Brown ,  James Douglass

    发明人： Jose Boyer ,  Benjamin Yerxa ,  Robert Plourde ,  Edward Brown ,  James Douglass

    IPC分类号： A61K31/7068 ,  A61K31/7072 ,  A61K31/7084 ,  C07H19/04 ,  C07H19/10 ,  C07H19/20 ,  C07H19/207 ,  C07H21/00 ,  A61K31/675

    CPC分类号： A61K31/7084 ,  A61K31/7068 ,  A61K31/7072 ,  C07H19/04 ,  C07H19/10 ,  C07H19/20 ,  C07H19/207 ,  C07H21/00

    摘要： The present invention is directed to a method of reducing intraocular pressure. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a nucleoside 5′-pyrophosphate pyranoside or analogue, which is defined by general Formula I. The method of the present invention is useful in the treatment or prevention of ocular hypertension, such as found in glaucoma, including primary and secondary glaucoma. The method can be used alone to reduce intraocular pressure. The method can also be used in conjunction with another therapeutic agent or adjunctive therapy commonly used to treat glaucoma to enhance the therapeutic effect of reducing the intraocular pressure. The present invention also provides a novel composition comprising a nucleoside 5′-pyrophosphate pyranoside or analogue.

    摘要翻译： 本发明涉及降低眼内压的方法。 该方法包括向受试者施用包含有效量的由通式I定义的核苷5'-焦磷酸吡喃糖苷或类似物的药物组合物。本发明的方法可用于治疗或预防高眼压症， 例如在青光眼中发现，包括原发性和继发性青光眼。 该方法可单独使用以降低眼内压。 该方法还可以与通常用于治疗青光眼的另一种治疗剂或辅助治疗联合使用，以增强降低眼内压的治疗效果。 本发明还提供了包含核苷5'-焦磷酸吡喃糖苷或类似物的新型组合物。